Aprogen Medicines Inc. (KRX:007460)

Revenue by Product

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2009	Dec 31, 2007	Dec 31, 2001	Dec 31, 2000	Dec 31, 1999
Medicine	60.12B
Medicine Growth	-4.51%
Steel	46.29B
Steel Growth	0.62%
Hardfacing	32.69B
Hardfacing Growth	8.80%
NUKON	8.46B
NUKON Growth	120.68%
Biosimilar	551.41M
Biosimilar Growth	-85.46%
Game	39.49M
Game Growth	-88.96%
Other	1.97B
Other Growth	-45.16%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2009	Dec 31, 2007	Dec 31, 2001	Dec 31, 2000	Dec 31, 1999
South Korea	139.72B
South Korea Growth	6.15%
Overseas	10.39B
Overseas Growth	-45.18%